OncoCyte Corp Purchase Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement, dated February 7, 2025, by and among the Company and the investors signatory thereto
Purchase Agreements
OncoCyte Corp
Biotechnology
2025
Securities Purchase Agreement, dated February 7, 2025, by and among the Company and the investors signatory thereto
Purchase Agreements
OncoCyte Corp
Biotechnology
2025
Securities Purchase Agreement, dated October 2, 2024, by and among the Company and the investors signatory thereto
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2024
Securities Purchase Agreement, dated April 11, 2024, by and among the Company and the investors signatory thereto
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2024
Form of Securities Purchase Agreement
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2023
Form of Securities Purchase Agreement, among us and certain investors, dated April 13, 2022
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2022
Purchase Agreement, dated February 4, 2021, between OncoCyte Corporation and Piper Sandler & Co., as representative of the underwriters named therein
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2021
Purchase Agreement between OncoCyte Corporation and Piper Jaffray & Co. dated February 8, 2019
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2019
Form of Securities Purchase Agreement, dated July 26, 2018, by and among OncoCyte Corporation and the investors signatory thereto
Purchase Agreements
OncoCyte Corp
Biotechnology
NY
2018
Form of Securities Purchase Agreement
Purchase Agreements
OncoCyte Corp
Biotechnology
CA
2018
Alternate form of Securities Purchase Agreement
Purchase Agreements
OncoCyte Corp
Biotechnology
CA
2016
Form of Securities Purchase Agreement
Purchase Agreements
OncoCyte Corp
Biotechnology
CA
2016